Total assets · 2011–2025
Elite Pharmaceuticals total assets
$126M+39.3% · FY2025
Elite Pharmaceuticals (ELTP) reported $126M in total assets for fiscal 2025, +39.3% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $126M | +39.3% | Open → |
| FY20242024-12-31 | $90.8M | +21.5% | Open → |
| FY20232023-12-31 | $74.7M | +41.7% | Open → |
| FY20222022-12-31 | $52.7M | +65.0% | Open → |
| FY20212021-12-31 | $31.9M | +11.4% | Open → |
| FY20202020-12-31 | $28.7M | +19.0% | Open → |
| FY20192019-12-31 | $24.1M | −8.7% | Open → |
| FY20182018-12-31 | $26.4M | −17.8% | Open → |
| FY20172017-12-31 | $32.1M | −11.4% | Open → |
| FY20162016-12-31 | $36.2M | +33.4% | Open → |
| FY20152015-12-31 | $27.1M | +5.6% | Open → |
| FY20142014-12-31 | $25.7M | +40.6% | Open → |
| FY20132013-12-31 | $18.3M | +76.2% | Open → |
| FY20122012-12-31 | $10.4M | +0.2% | Open → |
| FY20112011-12-31 | $10.3M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +19.6%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals total assets |url=https://companiesranked.com/en/company/elite-pharmaceuticals/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals total assets. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/total-assetsBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001493152-26-007104 · February 17, 2026
{{cite web |title=Elite Pharmaceuticals total assets — 10-Q (0001493152-26-007104) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226007104/form10-q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.